Filing Details
- Accession Number:
- 0001209191-13-029245
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-28 19:55:32
- Reporting Period:
- 2013-05-24
- Filing Date:
- 2013-05-28
- Accepted Time:
- 2013-05-28 19:55:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1356857 | Trius Therapeutics Inc | TSRX | Pharmaceutical Preparations (2834) | 201320630 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1478832 | Ken Bartizal | C/O Trius Therapeutics, Inc. 6310 Nancy Ridge Dr, # 105 San Diego CA 92121 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-05-24 | 12,000 | $7.93 | 98,927 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2012
Billionaire Hedge Funds
